SCHEMBL28124

SCHEMBL28124

CCCCCCCCCCCCCCCC(=O)NC(Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.67
ITGB3 P05106 3/20 0.66
ITGA2B P08514 3/20 0.66
GRIA1 P42261 1/20 0.62
CNR1 P21554 1/20 0.58
ALDH1A1 P00352 1/20 0.57
EPHX2 P34913 1/20 0.57
CHRND Q07001 5/20 0.56
NOD1 Q9Y239 1/20 0.56
CHRNA1 P02708 1/20 0.56
CHRNG P07510 1/20 0.56
CHRNB1 P11230 1/20 0.56
FOLH1 Q04609 1/20 0.54
NAALAD2 Q9Y3Q0 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6651208 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL6651206 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL4581440 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL16466484 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL4580946 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL4582828 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL8371127 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL3452191 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL13279358 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL3802383 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113563219-B L-tyrosine derivative and spherical mesoporous silica nanoparticle as well as preparation methods and applications thereof 沈阳药科大学 2023-12-26 CN claimed
CN-113563219-A L-tyrosine derivative and spherical mesoporous silica nanoparticle as well as preparation method and application thereof 沈阳药科大学 2021-10-29 CN claimed
EP-2724712-B1 Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone COGNIS IP MAN GMBH (DE) 2015-03-18 EP claimed
EP-2724712-A1 Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone Cognis IP Management GmbH (DE) 2014-04-30 EP claimed
US-20100183527-A1 Cosmetic Compositions Comprising Sclareolide and Hesperidin Methyl Chalcone COGNIS IP MANAGEMENT GMBH (DE) 2010-07-22 US claimed
EP-2164454-A1 COSMETIC COMPOSITIONS COMPRISING SCLAREOLIDE AND HESPERIDIN METHYL CHALCONE Cognis IP Management GmbH (DE) 2010-03-24 EP claimed
EP-2014276-A1 Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone Cognis IP Management GmbH (DE) 2009-01-14 EP claimed
WO-2008155048-A1 COSMETIC COMPOSITIONS COMPRISING SCLAREOLIDE AND HESPERIDIN METHYL CHALCONE COGNIS IP MANAGEMENT GMBH (DE) 2008-12-24 WO claimed
EP-0707844-A2 Liposome delivery of compositions to enhance tanning and repair UV damage CALIFORNIA SUNCARE INC. (US) 1996-04-24 EP claimed
US-4844884-A TYROSINE DERIVATIVES AND ADENOSINE-5'-PHOSPHATES INDUCHEM AG (CH) 1989-07-04 US claimed
US-20240382403-A1 COSMETIC, DERMATOLOGICAL OR COSMECEUTICAL TREATMENT, IN PARTICULAR PROPIGMENTING SEDERMA (FR) 2024-11-21 US disclosed
EP-4422591-A1 COSMETIC, DERMATOLOGICAL OR COSMECEUTICAL TREATMENT, IN PARTICULAR PROPIGMENTING SEDERMA (FR) 2024-09-04 EP disclosed
WO-2024065882-A1 AMINO ACID-BASED WATER-BASED LIQUID, PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院过程工程研究所 2024-04-04 WO disclosed
CN-113563219-B L-tyrosine derivative and spherical mesoporous silica nanoparticle as well as preparation methods and applications thereof 沈阳药科大学 2023-12-26 CN disclosed
CN-115400258-B Amino acid-based aqueous liquid, preparation method and application thereof 中国科学院过程工程研究所 2023-11-21 CN disclosed
US-6649149-B2 Tyrosine derivative and aliphatic polyol activator DIJA ZEIST B.V. (NL) 2003-11-18 US disclosed
US-20030118527-A1 Tanning preparation for the skin DIJA ZEIST B.V. 2003-06-26 US disclosed
EP-0707844-A2 Liposome delivery of compositions to enhance tanning and repair UV damage CALIFORNIA SUNCARE INC. (US) 1996-04-24 EP disclosed
US-4844884-A TYROSINE DERIVATIVES AND ADENOSINE-5'-PHOSPHATES INDUCHEM AG (CH) 1989-07-04 US disclosed
US-3971701-A FATTY ACID, ESTER OR N-ACYLAMINO ACID SURFACTANT AJINOMOTO CO., INC. (JA) 1976-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100183527-A1 Cosmetic Compositions Comprising Sclareolide and Hesperidin Methyl Chalcone HES1, CUTA, MC1R FAAH 3921/4885ITGB3 4289/4885ITGA2B 4469/4885
US-20240382403-A1 COSMETIC, DERMATOLOGICAL OR COSMECEUTICAL TREATMENT, IN PARTICULAR PROPIGMENTING TYR, TH, MITF FAAH 279/4885ITGB3 3698/4885ITGA2B 3897/4885
US-20030118527-A1 Tanning preparation for the skin TELO2, TDO2, TAOK2 FAAH 67/4885ITGB3 4722/4885ITGA2B 4863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.